Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Netherlands

 

European dental markets “could take years to recover from COVID”

As HBI Intelligence reviews the impact of COVID-19, HBI has been talking to operators and analysts. One EU-based operator says many markets across Europe will struggle to recover once the COVID-19 crisis has passed. Here is his view of where will be worst hit - and where we may see a surprising rebound.

Dutch physiotherapy group makes plans to go national

Dutch physiotherapy specialist TopzorgGroep has recently gained new investor. HBI talks to a Netherlands-based consultant about how the group could become a notable player in a largely chain-free market.

Korian targets top slot after large Dutch acquisition

Pan-European nursing home group Korian has made its largest Dutch acquisition to date, putting it in touching distance of rival Orpea for the number one market position in the Netherlands. We speak to a local consultant who gives us background on the assets.

Interview: Carlos Fernández de Araoz, partner and head of senior housing at Azora

Spanish real-estate investor Azora created a listed healthcare investment arm, Adriano Care, this summer. The REIT has just acquired its first assets and plans to invest €250m in Spanish senior residential care. We speak to Azora's head of senior housing, Carlos Fernández de Araoz, about the market, business strategy and future plans for Adriano.

Long-term care underpins strong growth forecast for Dutch healthcare

The total Dutch healthcare services market is forecast to grow from €83bn in 2021 to €98bn in 2025, an increase of over 18%, buoyed by demand for long-term care. The forecast by the Dutch Central Statistics Bureau (CBS) comes at a time when the country's nursing home sector is transitioning to further provision from the for-profit sector.

€10bn battle of the labs as Unilabs and Synlab mull 2020 sales

Europe's largest lab groups could both sell in 2020, with Apax appointing Rothschild to explore a sale of Unilabs while Synlab's majority owner Cinven is also weighing up an exit. The sale values including debt could potentially reach €10bn combined.

Find Us